TABLE 1.
Demographics and clinical characteristics of the study population
| Parameter | Values by category |
P valuea | ||
|---|---|---|---|---|
| All (n = 63) | Female (n = 12, 19%) | Male (n = 51, 81%) | ||
| Ageb | 55.0 (48.5, 61.0) | 56.0 (49.5, 62.3) | 54.0 (48.0, 61.0) | 0.563 |
| White (%) | 60.3 | 25 | 68.6 | 0.005 |
| Current CD4 T cell countsb | 164 (80, 390) | 330 (126, 453) | 155 (77, 285) | 0.134 |
| EDI (yrs)b | 14.0 (9.75, 19.0) | 17.0 (15.5, 19.0) | 13.0 (8.75, 18.3) | 0.085 |
| Estimated LT ART (yrs)b | 6.07 (2.74, 9.43) | 9.09 (6.15, 13.45) | 5.04 (2.32, 8.50) | 0.076 |
a
P values were calculated for continuous variables using Mann-Whitney U test and for categorical variables using the χ2 test between female and male sex.
b
Data are expressed as median (interquartile range). ART, antiretroviral therapy; LT, lifetime; EDI, estimated duration of infection.